Mats Wahlstrom - Aug 13, 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director, 10%+ Owner
Signature
/s/ Sean Murphy, Attorney-in-Fact for Mats Wahlstrom
Stock symbol
TLSI
Transactions as of
Aug 13, 2024
Transactions value $
$0
Form type
4
Date filed
8/21/2024, 08:48 PM
Previous filing
Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Director stock option (right to buy) Award $0 +15K $0.00 15K Aug 13, 2024 Common Stock 15K $5.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall fully vest on the one-year anniversary of the grant date of August 13, 2024, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.